查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948063

体外诊断帮浦市场依产品类型、应用、最终用户、自动化程度、流速及材料划分，全球预测，2026-2032年

In-Vitro Diagnostics Pumps Market by Product Type, Application, End User, Automation Level, Flow Rate, Material - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年体外诊断帮浦市场价值为 2.3595 亿美元，预计到 2026 年将成长至 2.4722 亿美元，预计到 2032 年将达到 3.7507 亿美元，复合年增长率为 6.84%。

关键市场统计数据
基准年 2025 2.3595亿美元
预计年份：2026年 2.4722亿美元
预测年份 2032 3.7507亿美元
复合年增长率 (%) 6.84%

体外诊断帮浦在现代检查室工作流程中扮演着至关重要的角色，它能够为临床检测、分子诊断、照护现场和科研实验室提供精准的流体处理。近年来，泵浦结构、材料科学和控制电子技术的进步，重新定义了人们对准确性、可重复性和生物相容性的期望。如今，从业人员需要能够最大限度地减少检体损失、降低污染风险并支援高度自动化工作流程的整合解决方案。

随着诊断路径与高通量分子方法和分散式检查模式的融合，泵浦技术必须平衡各种不同的性能需求。本导言概述了构成当前格局的技术基础、运作驱动因素和相关人员的优先事项。它透过强调可靠性、法规遵循和互通性是製造商和最终用户始终关注的重点，为后续分析提供了框架。本文进一步将泵浦置于更广泛的检查室生态系统中，指出资料完整性、通量一致性和可维护性决定了任何流体解决方案的实际价值。这有助于读者理解下文讨论的市场区隔、区域趋势、政策影响和策略建议。

自动化、分散式检测和分子诊断如何重塑帮浦的设计重点、连接期望和服务模式

体外诊断帮浦的市场格局正在经历一场变革，其驱动力包括自动化、分散式检测以及分子诊断方法的扩展。自动化正从独立设备转向将帮浦作为整合子系统而非独立周边设备设备的互联平台。这种转变推动了对数位化控制、通讯标准和可预测维护週期的需求，促使供应商优先考虑模组化和软体驱动的诊断技术。

分析2025年关税及其对供应链韧性、采购週期和製造地决策的策略影响

2025年的政策转变和关税给体外诊断帮浦的供应商和买家都带来了复杂的营运摩擦。关税导致关键零件和原材料的投入成本波动，促使企业重新评估供应基地，并加速调整其进出口策略。为此，製造商加快了供应来源多元化，探索近岸外包机会，并加强了与零件供应商的谈判，以维持利润率和供应的连续性。

综合細項分析，将产品架构、应用需求、最终用户优先顺序、自动化程度、流程控制和材料选择连结起来

细分市场提供了一个框架，用于理解技术选择、临床需求和采购优先顺序之间的交集，涵盖产品类型、应用、最终用户、自动化程度、流速和材料选择等方面。在产品类型方面，注射式帮浦——包括公分级、多通道和单通道注射帮浦——以及蠕动式、旋转式、双注射器和单注射器配置，在精准度、脉动和可维护性方面各有优劣。这些差异决定了它们在临床诊断、分子检查室、照护现场检验设备和研究环境中的最佳应用场景。基于应用的区分錶明，临床诊断中的血液学、免疫化学和微生物学需要稳健且最大限度减少污染的流体控制，而DNA定序、ELISA和PCR等分子诊断应用则需要超高精度的微量处理和严格的污染控制。就地检验需要紧凑、坚固耐用的泵，用于血液气体分析和血糖监测，而生物技术和製药研究实验室则优先考虑柔软性和化学相容性。

区域趋势和监管环境正在影响主要全球市场的采购行为、服务模式和产品设计重点。

区域趋势受法规结构、临床实践模式和供应链结构的影响，这为製造商、经销商和检查室营运商创造了独特的机会和挑战。在美洲，临床诊断网络和大型医院系统推动了对扩充性和可维护解决方案的需求，而私营部门的积极参与则促进了竞争性筹资策略和基本契约。北美检查室网路互通性，以支援认证流程。

供应商如何透过模组化设计、服务品质、监管应对力和策略合作伙伴关係实现差异化，从而占据技术和临床领域的细分市场

体外诊断帮浦领域的竞争格局主要集中在技术差异化、服务能力和监管经验方面。拥有深厚专业知识的公司正致力于开发模组化设计，以简化检验和维护流程，并建立全面的文件包，从而支援在临床和研究环境中快速部署。与试剂供应商、仪器整合商和系统整合商建立策略伙伴关係，透过展示端到端的工作流程优势，增强解决方案的黏性并加速其应用。

为满足不断变化的临床和营运需求，提供如何协调产品蓝图、供应链、材料策略和数位化连接方面的实用建议

产业领导者应采取务实的产品组合策略，使产品开发与新兴的临床路径和营运需求保持一致。优先发展模组化泵平台，这些平台支援多种产品类型，并可适应各种配置，包括离心泵、蠕动泵、旋转泵和注射泵，从而最大限度地重复利用核心控制系统，并简化跨多个应用的检验。加大材料研发投入，拓展聚四氟乙烯（PTFE）、聚氯乙烯（PVC）和硅胶等材料的选择范围，以解决化学和生物相容性问题，同时确保不影响可製造性。

对问卷的输入内容、验证过程以及用于得出可操作、可復现的行业洞察的分析方法进行透明的解释。

本研究整合了一手和二手资料，对体外诊断帮浦的市场趋势进行了系统性且可重复的分析。一级资讯来源包括对技术领导者、采购专业人员和检查室管理人员的访谈，以及对产品规格和服务内容的系统性检验。二级资讯来源包括对监管指南、检查室规范、专利和供应商技术文献的审查，以检验性能声明并识别创新趋势。

综合考虑技术、营运和政策因素，提出指导策略选择和实施重点的结论性观点。

总而言之，体外诊断帮浦处于精密工程、临床需求和实际操作三者交会点。泵浦控制、材料和连接方面的技术进步，使得检测更加精准，并能更顺畅地整合到自动化工作流程中。同时，去中心化和分子诊断技术的进步正在重塑帮浦的运作环境。政策和关税趋势的变化使得供应链策略变得愈发重要，迫使製造商重新思考采购、区域组装和库存管理方法，以维持生产的连续性和可预测性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 体外诊断帮浦市场（依产品类型划分）

  • 离心式
  • 蠕动
    • 多通道
    • 单通道
  • 旋转
  • 注射器
    • 双注射器
    • 单支注射器

9. 体外诊断帮浦市场依应用领域划分

  • 临床诊断
    • 血液学
    • 免疫化学
    • 微生物学
  • 分子诊断
    • DNA定序
    • ELISA
    • PCR
  • 即时检测
    • 血气分析
    • 血糖监测
  • 研究所
    • 生物技术
    • 药物研究

第十章 体外诊断帮浦市场（依最终用户划分）

  • 学术机构
  • 诊断检查室
  • 医院
  • 製药公司

第十一章 体外诊断帮浦市场（依自动化程度划分）

  • 全自动
  • 手动的
  • 半自动

12. 体外诊断帮浦市场（依流速划分）

  • 高流速
  • 低流速
  • 中等流速

第十三章 体外诊断帮浦市场（依材料划分）

  • PTFE
  • PVC
  • 硅酮

第十四章 体外诊断帮浦市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 体外诊断帮浦市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国体外诊断帮浦市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国体外诊断帮浦市场

第十八章：中国体外诊断帮浦市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Diener Precision Pumps Ltd.
  • F. Hoffmann-La Roche Ltd
  • Fluid-o-Tech srl
  • Grifols, SA
  • Hologic, Inc.
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Qiagen NV
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4F7A6D4FB714

The In-Vitro Diagnostics Pumps Market was valued at USD 235.95 million in 2025 and is projected to grow to USD 247.22 million in 2026, with a CAGR of 6.84%, reaching USD 375.07 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 235.95 million
Estimated Year [2026] USD 247.22 million
Forecast Year [2032] USD 375.07 million
CAGR (%) 6.84%

The in-vitro diagnostics pumps sector plays a foundational role in modern laboratory workflows by enabling precise fluid handling across clinical, molecular, point-of-care, and research environments. Over recent years, technical evolution in pump architectures, materials science, and control electronics has reshaped expectations for accuracy, reproducibility, and biocompatibility. Practitioners now expect integrated solutions that minimize sample loss, reduce contamination risk, and support increasingly automated workstreams.

As diagnostic pathways converge with high-throughput molecular methods and decentralized testing models, pump technologies must reconcile diverse performance requirements. This introduction outlines the technological substrates, operational drivers, and stakeholder priorities that define the current landscape. It frames the subsequent analysis by emphasizing reliability, regulatory compliance, and interoperability as persistent priorities for manufacturers and end users alike. The narrative also situates pumps within broader laboratory ecosystems, where data integrity, throughput consistency, and serviceability determine the practical value of any fluidics solution. In doing so, it prepares the reader to interpret segmentation, regional dynamics, policy impacts, and strategic recommendations presented in later sections.

How automation, decentralization of testing, and molecular diagnostics are reshaping pump design priorities, connectivity expectations, and service models

The landscape for in-vitro diagnostics pumps is undergoing transformative shifts driven by automation, decentralization of testing, and expanding molecular methodologies. Automation is moving beyond singular instrument islands toward interconnected platforms that embed pumps as integral subsystems rather than standalone peripherals. This shift elevates requirements for digital control, communication standards, and predictable maintenance cycles, prompting suppliers to prioritize modularity and software-driven diagnostics.

Simultaneously, point-of-care expansion and the rise of near-patient testing are compressing device footprints and increasing demand for compact, low-power pumps that maintain clinical-grade accuracy. Molecular diagnostics, including PCR and DNA sequencing, demand exceptional precision in low-volume transfers and contamination control, accelerating adoption of materials and designs that minimize adsorption and carryover. Materials science advances, such as biocompatible tubing and chemically resistant components, complement these trends. Finally, serviceability and total cost of ownership considerations are reshaping procurement decisions, with purchasers seeking predictable life-cycle performance and straightforward field maintenance. These converging forces are redefining product road maps and partnership strategies across the supply chain.

Analysis of 2025 tariff actions and their strategic implications for supply chain resilience, procurement cycles, and manufacturing footprint decisions

Policy shifts and tariff actions in 2025 introduced a complex layer of operational friction for suppliers and purchasers of in-vitro diagnostics pumps. Tariff measures altered input costs for key components and raw materials, generated re-evaluation of supplier footprints, and encouraged companies to reassess import-export strategies. In response, manufacturers accelerated supplier diversification, explored nearshoring opportunities, and intensified negotiations with component vendors to preserve margin and continuity of supply.

The cumulative impact extended beyond direct cost pressures. Procurement cycles elongated as buyers sought clarity on landed costs and long-term contractual terms. Some organizations pursued localized assembly or partnered with regional contract manufacturers to reduce exposure to cross-border duties. Transitionary operational measures included tighter inventory management and prioritized allocation of constrained components to critical product lines. Regulatory compliance and customs administration also required increased administrative attention, prompting firms to invest in trade expertise and to model tariff scenarios for procurement planning. Collectively, these adaptations increased organizational focus on supply chain resilience and strategic sourcing as essential capabilities for sustaining product availability and customer trust.

Comprehensive segmentation insight that connects product architectures, application demands, end-user priorities, automation levels, flow regimes, and material choices

Segmentation provides the framework to understand where engineering choices, clinical needs, and procurement priorities intersect across product type, application, end user, automation, flow rate, and material selection. By product type, centrifugal, peristaltic with multi-channel and single-channel variants, rotary, and syringe pumps with dual and single syringe configurations each address distinct accuracy, pulsation, and maintenance trade-offs; these differences determine optimal placement within clinical diagnostics, molecular labs, point-of-care devices, and research environments. Application-driven differentiation illustrates how hematology, immunochemistry, and microbiology within clinical diagnostics demand robust, contamination-minimizing fluidics, while molecular diagnostics areas such as DNA sequencing, ELISA, and PCR require ultra-precise micro-volume handling and stringent contamination controls. Point-of-care testing needs compact, robust pumps tailored for blood gas analysis and glucose monitoring, whereas research laboratories oriented to biotechnology and pharmaceutical research prioritize flexibility and chemical compatibility.

End users including academic institutes, diagnostic laboratories, hospitals, and pharmaceutical companies impose varied procurement cycles, service expectations, and validation requirements, driving manufacturers to offer tiered support and documentation. Automation level choices-fully automated, manual, and semi-automated-reflect operational priorities for throughput, operator skill, and lab layout. Flow rate considerations across high, medium, and low classes influence pump selection according to assay throughput and volume precision. Material selection among PTFE, PVC, and silicone balances chemical resistance, biocompatibility, and cost, with each material informing cleaning protocols and longevity. Together, these segmentation dimensions enable manufacturers and purchasers to align product attributes with clinical and operational objectives.

Regional dynamics and regulatory landscapes that shape procurement behavior, service models, and product design priorities across key global markets

Regional dynamics create distinct opportunities and constraints for manufacturers, distributors, and laboratory operators, shaped by regulatory frameworks, clinical practice patterns, and supply chain topology. In the Americas, clinical diagnostics networks and large hospital systems drive demand for scalable, serviceable solutions, while strong private-sector participation encourages competitive procurement strategies and value-based contracts. North American laboratory networks emphasize interoperability with laboratory information systems and compliance documentation that supports accreditation processes.

Europe, Middle East & Africa presents a heterogeneous regulatory and reimbursement landscape that rewards suppliers able to navigate diverse approval pathways and to offer flexible commercial models. In several markets, centralized public procurement and stringent quality assurance processes favor established partners with robust local support. The Asia-Pacific region combines rapid adoption of advanced molecular techniques with strong domestic manufacturing capabilities in several markets; this environment fosters price sensitivity alongside demand for innovative, compact designs suited to high-throughput and decentralized testing contexts. Across regions, manufacturers must tailor service networks, regulatory dossiers, and channel strategies to local clinical workflows and procurement behaviors to achieve durable adoption.

How suppliers differentiate through modular design, service excellence, regulatory depth, and strategic partnerships to capture technical and clinical niches

Competitive dynamics within the in-vitro diagnostics pumps space center on technological differentiation, service capability, and regulatory experience. Companies with deep domain expertise invest in modular designs that simplify validation and maintenance, and they build comprehensive documentation packages to support rapid deployment in clinical and research settings. Strategic partnerships with reagent suppliers, instrument integrators, and systems integrators enhance solution stickiness and accelerate adoption by demonstrating end-to-end workflow benefits.

Leading suppliers emphasize quality management systems, responsive field service, and spare parts logistics to minimize downtime for high-use environments such as hospital laboratories and major diagnostic networks. Others focus on specialized niches-compact pumps for point-of-care platforms or chemically resistant fluidics for pharmaceutical laboratories-to avoid direct competition and to capture premium technical segments. Channel strategies vary from direct institutional sales to distributor-led models, with many firms combining approaches to balance reach and technical support. Across the competitive set, investment in firmware security, interoperability, and validation tools increasingly defines differentiation as buyers prioritize solutions that reduce integration risk and total operational disruption.

Practical recommendations for aligning product road maps, supply chains, materials strategy, and digital connectivity to meet evolving clinical and operational needs

Industry leaders should adopt a pragmatic portfolio strategy that aligns product development with emerging clinical pathways and operational demands. Prioritize modular pump platforms that support multiple product types and can be adapted across centrifugal, peristaltic, rotary, and syringe configurations, thereby maximizing reuse of core control systems and simplifying validation across multiple applications. Invest in materials research to expand options among PTFE, PVC, and silicone in order to address chemical compatibility and biocompatibility concerns without sacrificing manufacturability.

Strengthen supply chain resilience by diversifying component sources and by evaluating regional assembly partnerships to mitigate tariff exposure and reduce lead-time variability. Enhance software and connectivity capabilities to support interoperability with laboratory information systems and to provide predictive maintenance insights that reduce downtime. Tailor commercial approaches to regional realities, recognizing that Americas, Europe, Middle East & Africa, and Asia-Pacific each demand distinct regulatory support, service models, and pricing strategies. Finally, deepen collaborations with clinical and research end users to co-develop features that address real-world workflow constraints, thereby accelerating adoption and improving clinical utility.

Transparent explanation of research inputs, validation processes, and analytical approaches used to derive practical and reproducible industry insights

This research synthesizes primary and secondary intelligence to produce a structured, reproducible analysis of the in-vitro diagnostics pumps landscape. Primary inputs include interviews with technical leaders, procurement specialists, and laboratory directors, combined with structured validation of product specifications and service offerings. Secondary inputs involve review of regulatory guidance, standards for laboratory practice, patents, and supplier technical literature to corroborate performance claims and to identify innovation trajectories.

Analytical methods emphasize cross-validation of qualitative insights with documented product capabilities and observable procurement behavior. Segmentation logic aligns product attributes with application requirements, end-user constraints, automation levels, flow regimes, and material choices. Scenario analysis examines supply chain sensitivities and policy impacts without relying on extrapolated sizing assumptions. Throughout, findings were subjected to peer review to ensure clarity, relevance, and operational applicability for stakeholders seeking to inform procurement, product development, and strategic partnerships.

Concluding perspective that synthesizes technological, operational, and policy drivers to guide strategic choices and adoption priorities

In summary, in-vitro diagnostics pumps sit at the intersection of engineering precision, clinical imperatives, and operational realities. Technological advances in pump control, materials, and connectivity are enabling higher fidelity assays and smoother integration into automated workflows, while decentralization and molecular methods are reshaping the contexts in which pumps must perform. Policy and tariff developments have heightened the importance of supply chain strategy, forcing manufacturers to reconsider sourcing, regional assembly, and inventory approaches to maintain continuity and predictability.

Looking ahead, successful organizations will combine modular hardware platforms, adaptable materials strategies, robust service networks, and secure digital interfaces to meet diverse user needs across clinical diagnostics, molecular testing, point-of-care, and research laboratories. Strategic alignment with end users and regional market dynamics will remain essential for durable adoption. The cumulative insight is that technical excellence must be paired with operational pragmatism to translate innovation into reliable, clinically accepted solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. In-Vitro Diagnostics Pumps Market, by Product Type

  • 8.1. Centrifugal
  • 8.2. Peristaltic
    • 8.2.1. Multi Channel
    • 8.2.2. Single Channel
  • 8.3. Rotary
  • 8.4. Syringe
    • 8.4.1. Dual Syringe
    • 8.4.2. Single Syringe

9. In-Vitro Diagnostics Pumps Market, by Application

  • 9.1. Clinical Diagnostics
    • 9.1.1. Hematology
    • 9.1.2. Immunochemistry
    • 9.1.3. Microbiology
  • 9.2. Molecular Diagnostics
    • 9.2.1. DNA Sequencing
    • 9.2.2. ELISA
    • 9.2.3. PCR
  • 9.3. Point Of Care Testing
    • 9.3.1. Blood Gas Analysis
    • 9.3.2. Glucose Monitoring
  • 9.4. Research Laboratories
    • 9.4.1. Biotechnology
    • 9.4.2. Pharmaceutical Research

10. In-Vitro Diagnostics Pumps Market, by End User

  • 10.1. Academic Institutes
  • 10.2. Diagnostic Laboratories
  • 10.3. Hospitals
  • 10.4. Pharmaceutical Companies

11. In-Vitro Diagnostics Pumps Market, by Automation Level

  • 11.1. Fully Automated
  • 11.2. Manual
  • 11.3. Semi Automated

12. In-Vitro Diagnostics Pumps Market, by Flow Rate

  • 12.1. High Flow Rate
  • 12.2. Low Flow Rate
  • 12.3. Medium Flow Rate

13. In-Vitro Diagnostics Pumps Market, by Material

  • 13.1. PTFE
  • 13.2. PVC
  • 13.3. Silicone

14. In-Vitro Diagnostics Pumps Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. In-Vitro Diagnostics Pumps Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. In-Vitro Diagnostics Pumps Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States In-Vitro Diagnostics Pumps Market

18. China In-Vitro Diagnostics Pumps Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Agilent Technologies, Inc.
  • 19.7. B. Braun Melsungen AG
  • 19.8. Becton, Dickinson and Company
  • 19.9. bioMerieux SA
  • 19.10. Bio-Rad Laboratories, Inc.
  • 19.11. Danaher Corporation
  • 19.12. DiaSorin S.p.A.
  • 19.13. Diener Precision Pumps Ltd.
  • 19.14. F. Hoffmann-La Roche Ltd
  • 19.15. Fluid-o-Tech s.r.l.
  • 19.16. Grifols, S.A.
  • 19.17. Hologic, Inc.
  • 19.18. Ortho Clinical Diagnostics
  • 19.19. PerkinElmer, Inc.
  • 19.20. Qiagen N.V.
  • 19.21. Siemens Healthineers AG
  • 19.22. Sysmex Corporation
  • 19.23. Tecan Group Ltd.
  • 19.24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CENTRIFUGAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CENTRIFUGAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CENTRIFUGAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MULTI CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MULTI CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MULTI CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ROTARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ROTARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ROTARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DUAL SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DUAL SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DUAL SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SINGLE SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY IMMUNOCHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY IMMUNOCHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BLOOD GAS ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BLOOD GAS ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BLOOD GAS ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HIGH FLOW RATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HIGH FLOW RATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY HIGH FLOW RATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY LOW FLOW RATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY LOW FLOW RATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY LOW FLOW RATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MEDIUM FLOW RATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MEDIUM FLOW RATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MEDIUM FLOW RATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 241. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 244. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 245. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 246. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 247. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 249. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 250. GCC IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 277. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 278. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 280. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 281. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 283. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 284. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 285. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 286. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 288. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 289. G7 IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 290. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 291. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 293. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 294. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 296. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 297. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2032 (USD MILLION)
  • TABLE 298. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 299. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 301. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 302. NATO IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY PERISTALTIC, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY SYRINGE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES IN-VITRO DIAGNOSTICS PUMPS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES